Skip to content

Haemonetics HAE Gross Carrying Amount

Gross Carrying Amount at other companies

Abbott logo
AbbottABT
Boston Scientific logo
Boston ScientificBSX
Medtronic logo
MedtronicMDT
ICU Medical logo
ICU MedicalICUI
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
ITG
Integer HoldingsITGR

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.

The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's gross carrying amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's gross carrying amount?
Haemonetics (HAE) reported gross carrying amount of $766.37M in Q4 2025.
How has Haemonetics's gross carrying amount changed year-over-year?
Haemonetics's gross carrying amount decreased by 0.5% year-over-year, from $770.46M to $766.37M.
What is the long-term trend for Haemonetics's gross carrying amount?
Over 2 years (2023 to 2025), Haemonetics's gross carrying amount has grown at a 6.5% compound annual growth rate (CAGR), from $672.72M to $762.87M.